| BCBS Florida Coverage Guidelines | Omalizumab (Xolair®, Omlyclo®) (09-J0000-44) | 2025-10-01 |
| BCBS Florida Coverage Guidelines | Pneumatic Compression Devices and (09-E0000-31) | 2025-10-01 |
| BCBS Florida Coverage Guidelines | Ponesimod (Ponvory™) Tablet (09-J3000-98) | 2025-10-01 |
| BCBS Florida Coverage Guidelines | Pulmonary Hypertension Drug Therapy (09-J1000-12) | 2025-10-01 |
| BCBS Florida Coverage Guidelines | Remestemcel-l-rknd (Ryoncil) Infusion (09-J5000-14) | 2025-10-01 |
| BCBS Florida Coverage Guidelines | Revakinagene taroretcel-lwey (Encelto) (09-J5000-17) | 2025-10-01 |
| BCBS Florida Coverage Guidelines | SARS-CoV-2 Monoclonal Antibodies (09-J3000-86) | 2025-10-01 |
| BCBS Florida Coverage Guidelines | Siponimod (Mayzent®) Tablets (09-J3000-35) | 2025-10-01 |
| BCBS Florida Coverage Guidelines | Subcutaneous Prophylactic Therapy for (09-J5000-12) | 2025-10-01 |
| BCBS Florida Coverage Guidelines | Teprotumumab (Tepezza®) Infusion (09-J3000-64) | 2025-10-01 |